Skip to content

High Flow Nasal Cannula on Exercise Endurance in COPD

Effects of High Flow Nasal Cannula on Exercise Endurance in Patients With COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03883256
Enrollment
15
Registered
2019-03-20
Start date
2018-05-25
Completion date
2019-11-30
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

High flow nasal cannula oxygen, exercise performance, COPD

Brief summary

Ventilation limitation has a significant adverse effects on cardiovascular function and cerebral oxygenation during exercise in patients with COPD. High flow nasal cannula (HFNC) has been shown to improve ventilation by washing out the anatomical dead space and permitting a better gas exchanges. Moreover, it is able to ensure the desired inspired oxygen fraction (FiO2) even at high level of patient's minute ventilation by minimizing the room air entrainment. The effects of HFNC on exercise performance in terms of hemodynamic changes and exercise endurance in COPD patients remain unclear. The primary purpose of this study is to examine the effects of HFNC on the exercise endurance in COPD patients. The investigator's secondary purpose is to investigate whether HFNC could improve efficiency of ventilation, leading to an improvement of hemodynamic and cerebral oxygenation response.

Detailed description

This is a randomized crossover study. Patients who have been diagnosed as COPD will be recruited from outpatient department. After signing informed consent form, patients undertake an incremental exercise test and two constant load exercise at the 70% of maximum workload achieved at a previous incremental exercise test on arm ergometer in two separate days. The constant load tests will be performed with HFNC and with nasal cannula at the same inhaled oxygen fraction in random order. The hemodynamics CO, SV, EF of all subjects during exercises will be measured by a bioelectrical impedance device (Physioflow), and cerebral oxygenation status (oxygenated hemoglobin (O2Hb), deoxygenated hemoglobin (HHb), total hemoglobin (tHb) was measured by a near infrared spectrophotometer (NIRS).

Interventions

DEVICEhigh flow nasal cannula

High flow nasal cannula is a device that delivered heated and humidified high flow gases to at or near body temperature to avoid drying and possible injury to the nasal mucosa. In this study, subjects perform a constant-load exercise test with high flow nasal cannula.

Nasal cannula is a device that delivered oxygen to patients. In this study, subjects perform a constant-load exercise test with nasal cannula.

Sponsors

Chang Gung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. with diagnosis of COPD 2. OPD patients 3. has no AE (within 1 month) 4. not receiving any O2 therapy at home 5. no smoking or quick

Exclusion criteria

1. fever 2. unstable hemodynamics at resting 3. orthopadeic or neurologic problems that limited exercise

Design outcomes

Primary

MeasureTime frameDescription
exercise time with high flow nasal cannulaend of the exercise test in the session of constant-load exercise test with high flow nasal cannula oxygen devicethe total duration that subjects performed constant-load exercise test with high flow nasal cannula oxygen device
exercise time with nasal cannulaend of the exercise test in the session of constant-load exercise test with nasal cannula oxygen devicethe total duration that subjects performed constant-load exercise test with nasal cannula oxygen device

Secondary

MeasureTime frameDescription
Difference in cardiac outputBaseline and 48 hours after baseline ]Difference in end-exercise cardiac output in constant-load exercise test between HFNCO and NC
Difference in stroke volumeBaseline and 48 hours after baseline ]Difference in end-exercise stroke volume in constant-load exercise test between HFNCO and NC
Difference in muscle tissue oxygenationBaseline and 48 hours after baseline ]Difference in end-exercise muscle tissue oxygenation in constant-load exercise test between HFNCO and NC
Difference in cerebral tissue oxygenationBaseline and 48 hours after baseline ]Difference in end-exercise cerebral tissue oxygenation in constant-load exercise test between HFNCO and NC

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026